Plaque Psoriasis clinical trials

Explore recruiting plaque psoriasis clinical trials.

Recruiting plaque psoriasis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Plaque Psoriasis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study of LY4100511 (DC-853) for the Treatment of Adult Participants with Moderate-to-Severe Plaque Psoriasis

Hungary, Poland, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Dose-Range Finding Study of ORKA-001 in Participants with Moderate-to-Severe Plaque Psoriasis

Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging study of Efficacy and Safety of SAR441566 in Adults with Moderate to Severe Plaque Psoriasis

Spain, Germany, Hungary, Portugal, Czechia, Poland +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1 study with topical cream RLS-1496 in patients with plaque psoriasis or Eczema

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Multicenter, Randomized, Double-blind, Placebo- controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants with Moderate to Severe Plaque Psoriasis

Spain, Poland, Hungary, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase 1b trial to study the safety and effect of ZP9830 in patients with plaque psoriasis

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Plaque Psoriasis trials by city

Plaque Psoriasis in Toronto Plaque Psoriasis in Vancouver Plaque Psoriasis in Montreal Plaque Psoriasis in Calgary Plaque Psoriasis in Edmonton Plaque Psoriasis in Ottawa Plaque Psoriasis in Winnipeg Plaque Psoriasis in Quebec City Plaque Psoriasis in Hamilton Plaque Psoriasis in Kitchener Plaque Psoriasis in London Plaque Psoriasis in Halifax Plaque Psoriasis in New York Plaque Psoriasis in Los Angeles Plaque Psoriasis in Chicago Plaque Psoriasis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease